Discount up to 35% for first purchase only this month.

Everclear Peptides logo

Everclear peptides.

Tirzepatide
Tirzepatide - Image 2

Tirzepatide

Price range: $90.00 through $155.00

Tirzepatide is a synthetic dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed by Eli Lilly — the first-in-class twincretin peptide.

Show COA

Description

Tirzepatide is a synthetic dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed by Eli Lilly — the first-in-class twincretin peptide. In Phase 3 SURPASS trials, Tirzepatide achieved up to 22.5% weight loss, surpassing Semaglutide’s results and establishing dual agonism as superior to single GLP-1 activation for metabolic endpoints. It serves as a critical comparator in research between single-mechanism (Semaglutide) and triple-mechanism (Retatrutide) approaches.

Quality Specifications

  • Purity: ≥99% (HPLC verified)
  • Compound: Tirzepatide
  • Molecular Weight: 4813.5 Da
  • Form: Lyophilized powder

Additional information

Weight0.02 lbs
Dimensions3.81 × 1.27 × 1.27 cm
Per Vial

15mg, 30mg

Reviews

There are no reviews yet.

Be the first to review “Tirzepatide”

Your email address will not be published. Required fields are marked *

I confirm I am 21+ years of age or older.

Purchasers must be 21 years of age or older.

The products shown on this website are intended strictly for laboratory research purposes only and are not for human or animal consumption in any form.